Earnings Preview: Hospira - Analyst Blog
30 Julho 2012 - 9:00AM
Zacks
Hospira Inc. (HSP)
is all set to announce its second-quarter 2012 results before the
market opens on August 1, 2012. The Zacks Consensus Estimate for
the second quarter of 2012 is 49 cents, reflecting an estimated
year-over-year decline of 47.9%. The slowdown in production at
Hospira’s facility in Rocky Mountain, North Carolina, is expected
to continue impacting earnings.
First-Quarter
Recap
Hospira’s first-quarter 2012
earnings (excluding special items) of 47 cents per share edged past
the Zacks Consensus Estimate of 46 cents. However, earnings fell
short of the year-ago figure by 49.5% due to lower revenues and
higher costs. On a reported basis (including special items), the
company earned 24 cents per share, down 72.7%.
Hospira came up with revenues of
$966 million in the first quarter, comfortably beating the Zacks
Consensus Estimate of $951 million. Revenues were, however, 3.6%
lower than the year-ago figure of $1.0 billion. (Read our full
coverage of the first quarter earnings report at Hospira Beats by a
Penny, Backs View ).
Agreement of Estimate
Revisions
Over the last 30 days, 3 of the 15
analysts covering Hospira for the second quarter of 2012 have
trimmed their earnings estimates with no upward movement. Similar
downward trends have been observed in earnings estimates movements
over the last 30 days for fiscal 2012 and fiscal 2013.
We believe that the ongoing
manufacturing issues at the company’s Rocky Mountain facility are
primarily responsible for the downward bias. Even though Hospira is
working hard to resolve the issue, it will remain a major overhang
on the stock, until fully resolved.
Magnitude of Estimate
Revisions
Given the downward bias in earnings
estimate revisions over the last month, earnings estimates for the
second quarter, fiscal 2012 and fiscal 2013 have gone down by a
penny and 2 cents each, respectively. Earnings estimates for the
second quarter, fiscal 2012 and fiscal 2013 currently stand at 49
cents, $2.11 and $2.65 respectively.
Surprise
History
Hospira has surpassed earnings
estimates in two of the last four quarters, in addition to
reporting in line earnings in the other two quarters. On average,
the earnings surprise was 16.92%.
Our
Recommendation
We have a Neutral recommendation on
Hospira. The stock carries a Zacks #3 Rank (Hold rating) in the
short run.
HOSPIRA INC (HSP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024